Analystreport

Supernus Pharmaceuticals Inc (NASDAQ: SUPN) was given a new $47.00 price target on by analysts at Piper Jaffray Companies. They now have a "hold" rating on the stock.

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com